Literature DB >> 19747750

Pathological confirmation of primary lung cancer following breast cancer.

M Tennis1, B Singh, A Hjerpe, M Prochazka, K Czene, P Hall, P G Shields.   

Abstract

PURPOSE: Studies have shown that women who survive breast cancer have an increased risk of a future primary lung cancer, though many are based only on data recorded in tumor registries and none have conducted pathological confirmation. Previous studies and future use of large registries may be affected by misdiagnosis.
METHODS: Pathological analysis was conducted on tumors from 110 women with breast cancer followed by lung cancer using morphology, Estrogen Receptor-alpha (ER), and Thyroid Transcription Factor-1 (TTF1). We developed an algorithm to classify lung tumors as unlikely lung cancer (score=1) to likely lung cancer (score=5).
RESULTS: Mean time to diagnosis of lung cancer after breast cancer was 13 years. 76% of breast tumors and 20% of lung tumors were positive for ER and 51% of lung tumors were positive for TTF-1. 86% of the lung tumors were probable primaries, 7% were probable metastases from the breast, and 7% were of undetermined status. 70% of probable metastases had a latency of longer than 10 years.
CONCLUSION: Prior studies identifying the association of breast cancer and breast cancer treatments with lung cancer are likely to reflect true associations not confounded by misdiagnosis, as evidenced by the low rate of misclassification detected in this study. Analysis of the years of diagnosis suggests that latency may not be an accurate criterion for assignment of primary status, which could be significant in a clinical setting. These data may also benefit future retrospective studies using large registries. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747750      PMCID: PMC2879479          DOI: 10.1016/j.lungcan.2009.08.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  37 in total

1.  Cancer risk in women with previous breast cancer.

Authors:  F Levi; V-C Te; L Randimbison; C La Vecchia
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

2.  Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.

Authors:  Josef Zamecnik; Roman Kodet
Journal:  Virchows Arch       Date:  2001-10-19       Impact factor: 4.064

3.  The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.

Authors:  Yih-Leong Chang; Yung-Chie Lee; Wei-Yu Liao; Chen-Tu Wu
Journal:  Lung Cancer       Date:  2004-05       Impact factor: 5.705

Review 4.  Second cancers after breast cancer treatment.

Authors:  Sister Mary Andrew Matesich; Charles L Shapiro
Journal:  Semin Oncol       Date:  2003-12       Impact factor: 4.929

5.  The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.

Authors:  Melvin Deutsch; Stephanie R Land; Mirsada Begovic; H Samuel Wieand; Norman Wolmark; Bernard Fisher
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

6.  Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors.

Authors:  Melissa B Ford; Alice J Sigurdson; Elaine S Petrulis; Chaan S Ng; Bonnie Kemp; Catherine Cooksley; Marsha McNeese; Beatrice J Selwyn; Margaret R Spitz; Melissa L Bondy
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

7.  Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.

Authors:  Mariusz Koda; Stanislaw Sulkowski; Luiza Kanczuga-Koda; Eva Surmacz; Mariola Sulkowska
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

8.  Lung cancer risks in women with previous breast cancer.

Authors:  M Prochazka; F Granath; A Ekbom; P G Shields; P Hall
Journal:  Eur J Cancer       Date:  2002-07       Impact factor: 9.162

9.  Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England.

Authors:  H S Evans; C M Lewis; D Robinson; C M Bell; H Møller; S V Hodgson
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

10.  Second primary cancers following breast cancer in the Japanese female population.

Authors:  H Tanaka; H Tsukuma; H Koyama; Y Kinoshita; N Kinoshita; A Oshima
Journal:  Jpn J Cancer Res       Date:  2001-01
View more
  4 in total

1.  Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.

Authors:  Michael T Milano; Huilin Li; Mitchell H Gail; Louis S Constine; Lois B Travis
Journal:  J Clin Oncol       Date:  2010-10-25       Impact factor: 44.544

2.  Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data.

Authors:  George Luta; Melissa B Ford; Melissa Bondy; Peter G Shields; James D Stamey
Journal:  Cancer Epidemiol       Date:  2013-01-03       Impact factor: 2.984

3.  Prognostic implication of isolated pulmonary nodules in patients with a history of breast cancer.

Authors:  Weigang Zhao; Chuanli Song; Shu Zhu; Zuodong Song
Journal:  J Cardiothorac Surg       Date:  2022-06-18       Impact factor: 1.522

4.  The risk of a second primary lung cancer after a first invasive breast cancer according to estrogen receptor status.

Authors:  Sara J Schonfeld; Rochelle E Curtis; William F Anderson; Amy Berrington de González
Journal:  Cancer Causes Control       Date:  2012-08-24       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.